Carlo de Notaristefani
Director/Board Member at Medarex, Inc.
Profile
Carlo de Notaristefani is on the board of Medarex, Inc. He previously held the position of Executive Vice President-Global Operations at Teva Pharmaceutical Industries Ltd., President-Technical Operations at Bristol Myers Squibb Co. and Senior Vice President-Global Finishing Solids at Aventis Pharmaceuticals, Inc. He received a doctorate from Università degli Studi di Napoli Federico II.
Carlo de Notaristefani active positions
| Companies | Position | Start |
|---|---|---|
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Director/Board Member | 2009-09-01 |
Former positions of Carlo de Notaristefani
| Companies | Position | End |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Operating Officer | 2019-10-01 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2011-06-30 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Training of Carlo de Notaristefani
| Università degli Studi di Napoli Federico II | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Carlo de Notaristefani
